Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 1-Year High at $20.94

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $20.94 and last traded at $20.83, with a volume of 197612 shares traded. The stock had previously closed at $20.16. Analyst Ratings Changes KNSA has been the topic of […]

Related Keywords

Canada ,Johnf Paolini ,Michaelr Megna , ,Tower Research Capital ,Altshuler Shaham Ltd ,News Ratings For Kiniksa Pharmaceuticals Daily ,Lazard Asset Management ,Kiniksa Pharmaceuticals Stock Performance ,Nasdaq ,Kiniksa Pharmaceuticals Ltd ,Royal Bank ,Securities Exchange Commission ,Advisors Inc ,Kiniksa Pharmaceuticals ,Get Free Report ,Exchange Commission ,Research Capital ,Asset Management ,Shaham Ltd ,Kiniksa Pharmaceuticals Daily ,Nasdaq Knsa ,Knsa ,Medical ,Stocks ,Technicals ,